Recombinant multi-species RPL10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPL10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a ribosomal protein that is a component of the 60S ribosome subunit. The related protein in chicken can bind to c-Jun and can repress c-Jun-mediated transcriptional activation. Some studies have detected an association between variation in this gene and autism spectrum disorders, though others do not detect this relationship. There are multiple pseudogenes of this gene dispersed throughout the genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
The Alternative Names of target: 60S ribosomal protein L10,AUTSX5,D0HXS648,DXHXS648,DXHXS648E,DXS648,DXS648E,L10,Laminin receptor homolog,Large ribosomal subunit protein uL16,MRXS35,NOV,Protein QM,QM,QM16,RPL10,Ribosomal protein L10,Rpl10,Tumor suppressor QM,na,uL16

Target products collectionGo to RPL10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10965-Ag-1/ GM-Tg-hg-IP10965-Ag-2 Human RPL10 protein Human
GM-Tg-rg-IP10965-Ag-1/ GM-Tg-rg-IP10965-Ag-2 Rat RPL10 protein Rat
GM-Tg-mg-IP10965-Ag-1/ GM-Tg-mg-IP10965-Ag-2 Mouse RPL10 protein Mouse
GM-Tg-cynog-IP10965-Ag-1/ GM-Tg-cynog-IP10965-Ag-2 Cynomolgus/Rhesus macaque RPL10 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10965-Ag-1/ GM-Tg-felg-IP10965-Ag-2 Feline RPL10 protein Feline
GM-Tg-cang-IP10965-Ag-1/ GM-Tg-cang-IP10965-Ag-2 Canine RPL10 protein Canine
GM-Tg-bovg-IP10965-Ag-1/ GM-Tg-bovg-IP10965-Ag-2 Bovine RPL10 protein Bovine
GM-Tg-equg-IP10965-Ag-1/ GM-Tg-equg-IP10965-Ag-2 Equine RPL10 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10965-Ag-1/ GM-Tg-hg-IP10965-Ag-2; GM-Tg-rg-IP10965-Ag-1/ GM-Tg-rg-IP10965-Ag-2;
GM-Tg-mg-IP10965-Ag-1/ GM-Tg-mg-IP10965-Ag-2; GM-Tg-cynog-IP10965-Ag-1/ GM-Tg-cynog-IP10965-Ag-2;
GM-Tg-felg-IP10965-Ag-1/ GM-Tg-felg-IP10965-Ag-2; GM-Tg-cang-IP10965-Ag-1/ GM-Tg-cang-IP10965-Ag-2;
GM-Tg-bovg-IP10965-Ag-1/ GM-Tg-bovg-IP10965-Ag-2; GM-Tg-equg-IP10965-Ag-1/ GM-Tg-equg-IP10965-Ag-2
Products Name RPL10 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RPL10
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPL10 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.